SE8404729D0 - 2,5-disubstituted-4(3h)-pyrimidones having histamine h?712-receptor antagonist activity - Google Patents
2,5-disubstituted-4(3h)-pyrimidones having histamine h?712-receptor antagonist activityInfo
- Publication number
- SE8404729D0 SE8404729D0 SE8404729A SE8404729A SE8404729D0 SE 8404729 D0 SE8404729 D0 SE 8404729D0 SE 8404729 A SE8404729 A SE 8404729A SE 8404729 A SE8404729 A SE 8404729A SE 8404729 D0 SE8404729 D0 SE 8404729D0
- Authority
- SE
- Sweden
- Prior art keywords
- alkyl
- inclusive
- integer
- atom
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/534,426 US4772704A (en) | 1983-09-21 | 1983-09-21 | 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8404729D0 true SE8404729D0 (sv) | 1984-09-20 |
| SE8404729L SE8404729L (sv) | 1985-03-22 |
| SE463209B SE463209B (sv) | 1990-10-22 |
Family
ID=24129972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8404729A SE463209B (sv) | 1983-09-21 | 1984-09-20 | 5-amino-2-/3-(3-piperidinometylfenoxi)propylamino/-4 (3h)-pyrimidon, saett att framstaella denna och en farmaceutisk beredning |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US4772704A (sv) |
| JP (1) | JPH0643310B2 (sv) |
| KR (1) | KR900001198B1 (sv) |
| AR (2) | AR242385A1 (sv) |
| AT (1) | AT387965B (sv) |
| AU (1) | AU583479B2 (sv) |
| BE (1) | BE900652A (sv) |
| CA (1) | CA1260463A (sv) |
| CH (1) | CH665840A5 (sv) |
| CS (1) | CS249147B2 (sv) |
| CY (1) | CY1561A (sv) |
| DD (1) | DD226881A5 (sv) |
| DE (1) | DE3434578A1 (sv) |
| DK (1) | DK162987C (sv) |
| ES (4) | ES8607253A1 (sv) |
| FI (1) | FI83868C (sv) |
| FR (1) | FR2552082B1 (sv) |
| GB (1) | GB2146994B (sv) |
| GR (1) | GR80439B (sv) |
| HK (1) | HK73790A (sv) |
| HU (1) | HU193227B (sv) |
| IE (1) | IE58083B1 (sv) |
| IL (1) | IL72990A (sv) |
| IT (1) | IT1176739B (sv) |
| LU (1) | LU85550A1 (sv) |
| NL (1) | NL8402898A (sv) |
| NO (1) | NO161561C (sv) |
| NZ (1) | NZ209572A (sv) |
| OA (1) | OA07820A (sv) |
| PT (1) | PT79256B (sv) |
| SE (1) | SE463209B (sv) |
| SG (1) | SG60890G (sv) |
| YU (1) | YU45205B (sv) |
| ZA (1) | ZA847345B (sv) |
| ZM (1) | ZM4984A1 (sv) |
| ZW (1) | ZW16084A1 (sv) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2873340B2 (ja) * | 1988-04-29 | 1999-03-24 | 武田薬品工業株式会社 | 抗生物質ｔａｎ―１０５７，その製造法および用途 |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN151188B (sv) * | 1978-02-13 | 1983-03-05 | Smith Kline French Lab | |
| ES477520A1 (es) * | 1978-02-25 | 1979-06-01 | Thomae Gmbh Dr K | Procedimiento para la preparacion de nuevas penicilinas. |
| PH16240A (en) * | 1978-04-11 | 1983-08-11 | Smith Kline French Lab | Process for making histamine antagonist |
| US4496567A (en) * | 1978-11-13 | 1985-01-29 | Smith Kline & French Laboratories Limited | Phenyl alkylaminopyrimidones |
| US4521418A (en) * | 1979-02-21 | 1985-06-04 | Smith Kline & French Laboratories Limited | Guanidinothiazolyl derivatives |
| AU531142B2 (en) * | 1979-04-04 | 1983-08-11 | Smith Kline & French Laboratories Limited | 2 amino- pyimindones |
| CA1140129A (en) * | 1979-08-21 | 1983-01-25 | Ronald J. King | 4-pyrimidone derivatives |
| ZW21281A1 (en) * | 1980-10-01 | 1981-11-18 | Smith Kline French Lab | Amine derivatives |
| US4352933A (en) * | 1981-02-06 | 1982-10-05 | Smithkline Beckman Corporation | Chemical methods and intermediates for preparing substituted pyrimidinones |
| US4468399A (en) * | 1981-12-28 | 1984-08-28 | Eli Lilly And Company | 2-[2-(2-Aminoalkyl-4-thiazolylmethylthio)alkyl]-amino-5-substituted-4-pyrimidones |
| NZ202797A (en) * | 1981-12-28 | 1985-08-30 | Lilly Co Eli | Pyrimidine derivatives and pharmaceutical compositions |
| GB8320505D0 (en) * | 1983-07-29 | 1983-09-01 | Smith Kline French Lab | Chemical compounds |
| CA1275097A (en) * | 1984-10-02 | 1990-10-09 | Fujio Nohara | Pyridyloxy derivatives |
-
1983
- 1983-09-21 US US06/534,426 patent/US4772704A/en not_active Expired - Fee Related
-
1984
- 1984-09-17 NZ NZ209572A patent/NZ209572A/en unknown
- 1984-09-18 ZA ZA847345A patent/ZA847345B/xx unknown
- 1984-09-18 ZW ZW160/84A patent/ZW16084A1/xx unknown
- 1984-09-18 FI FI843643A patent/FI83868C/sv not_active IP Right Cessation
- 1984-09-18 IL IL72990A patent/IL72990A/xx not_active IP Right Cessation
- 1984-09-18 ZM ZM49/84A patent/ZM4984A1/xx unknown
- 1984-09-19 CA CA000463533A patent/CA1260463A/en not_active Expired
- 1984-09-19 NO NO843726A patent/NO161561C/no unknown
- 1984-09-19 ES ES536054A patent/ES8607253A1/es not_active Expired
- 1984-09-19 YU YU1613/84A patent/YU45205B/xx unknown
- 1984-09-20 AU AU33351/84A patent/AU583479B2/en not_active Ceased
- 1984-09-20 CS CS847103A patent/CS249147B2/cs unknown
- 1984-09-20 JP JP59195868A patent/JPH0643310B2/ja not_active Expired - Lifetime
- 1984-09-20 FR FR8414463A patent/FR2552082B1/fr not_active Expired
- 1984-09-20 DK DK450484A patent/DK162987C/da active
- 1984-09-20 OA OA58396A patent/OA07820A/xx unknown
- 1984-09-20 IE IE240684A patent/IE58083B1/en not_active IP Right Cessation
- 1984-09-20 SE SE8404729A patent/SE463209B/sv not_active IP Right Cessation
- 1984-09-20 GB GB08423863A patent/GB2146994B/en not_active Expired
- 1984-09-20 CH CH4510/84A patent/CH665840A5/de not_active IP Right Cessation
- 1984-09-20 HU HU843539A patent/HU193227B/hu not_active IP Right Cessation
- 1984-09-20 DE DE19843434578 patent/DE3434578A1/de not_active Withdrawn
- 1984-09-20 IT IT22744/84A patent/IT1176739B/it active
- 1984-09-21 AR AR84298041A patent/AR242385A1/es active
- 1984-09-21 PT PT79256A patent/PT79256B/pt not_active IP Right Cessation
- 1984-09-21 AT AT0300984A patent/AT387965B/de not_active IP Right Cessation
- 1984-09-21 GR GR80439A patent/GR80439B/el unknown
- 1984-09-21 LU LU85550A patent/LU85550A1/fr unknown
- 1984-09-21 KR KR1019840005791A patent/KR900001198B1/ko not_active IP Right Cessation
- 1984-09-21 NL NL8402898A patent/NL8402898A/nl not_active Application Discontinuation
- 1984-09-21 DD DD84267496A patent/DD226881A5/de not_active IP Right Cessation
- 1984-09-21 BE BE0/213705A patent/BE900652A/fr not_active IP Right Cessation
-
1985
- 1985-06-14 ES ES544213A patent/ES8704465A1/es not_active Expired
-
1986
- 1986-01-31 ES ES551500A patent/ES8704155A1/es not_active Expired
- 1986-01-31 ES ES551501A patent/ES8702897A1/es not_active Expired
-
1987
- 1987-09-18 AR AR87308766A patent/AR242789A1/es active
-
1990
- 1990-07-21 SG SG608/90A patent/SG60890G/en unknown
- 1990-09-20 HK HK737/90A patent/HK73790A/xx unknown
-
1991
- 1991-03-22 CY CY1561A patent/CY1561A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2067987B (en) | 3,4-disubstituted-1,2,5-thiadiazole-1-oxides and 1,1 dioxides | |
| NZ284654A (en) | Oxazolyl substituted 3,5-dioxo-oxadiazolidine or 2,4-dioxo-thiazolidine derivatives and medicaments | |
| ES458689A1 (es) | Procedimiento de preparacion de nuevos derivados del ditiol-1,2. | |
| ES462700A1 (es) | Procedimiento para la preparacion de nuevas 1h-pirazolo(3,4-b)piridinas. | |
| ES469900A1 (es) | Un procedimiento para la preparacion de derivados de m-feno-xibenzamida | |
| FR2678272B1 (fr) | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. | |
| IE41244L (en) | Pyridobenzodiazepinones | |
| SE8404729D0 (sv) | 2,5-disubstituted-4(3h)-pyrimidones having histamine h?712-receptor antagonist activity | |
| IE43575L (en) | Erythromycin derivatives | |
| ES470783A1 (es) | Procedimiento de preparacion de aminoalcoxibenzofuranos | |
| IE45702L (en) | Pyridobenzodiazepinones | |
| NZ296285A (en) | Inhibiting physiological conditions associated with bradykinin using a benzothiophene such as raloxifene | |
| ATE56962T1 (de) | 3,4-disubstituierte-1,2,5-oxadiazole mit histamin h2-rezeptor-antagonisten-aktivitaet. | |
| ES448696A1 (es) | Procedimiento para la preparacion de 4-fenil-imidazolinas sustituidas. | |
| DK10684A (da) | Farmaceutisk praeparat til behandling af peptisk ulcus | |
| PH15866A (en) | Substituted 4-amino 2,6-diaryl-tetrahydrothiopyrans and salts thereof,and use as antidepressants | |
| GB1472325A (en) | Substituted-3,3a,4,5,6,7-hexahydropyrazolo-4,3-c-pyridines | |
| ES8301933A1 (es) | "procedimiento para la preparacion de derivados de 4-(5)-alcohil-mercaptoimidazoles". | |
| JPS51118832A (en) | A non-medical antibacterial, 3-pyridyl substituted guanidine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8404729-9 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8404729-9 Format of ref document f/p: F |